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Abstract
We piloted a community-based intervention to improve outcomes among adolescents living with HIV who were transitioning to adult-oriented care in Lima, Peru. We assessed feasibility and potential effectiveness, including within-person
changes in self-reported adherence, psychosocial metrics (NIH Toolbox), and transition readiness (“Am I on TRAC”
questionnaire, “Got Transition” checklist). From October 2019 to January 2020, we enrolled 30 adolescents (15–21 years).
The nine-month intervention consisted of logistical, adherence and social support delivered by entry-level health workers
and group sessions to improve health-related knowledge and skills and social support. In transition readiness, we observed
within-person improvements relative to baseline. We also observed strong evidence of improvements in adherence, social
support, self-efficacy, and stress, which were generally sustained three months post-intervention. All participants remained
in treatment after 12 months. The intervention was feasible and potentially effective for bridging the transition to adult
HIV care. A large-scale evaluation, including biological endpoints, is warranted.
Keywords Adolescents · Social support · Adherence · Differentiated care · HIV care continuum

Resumen

Piloteamos una intervención comunitaria para mejorar los resultados de adolescentes viviendo con el VIH que se encontraban en transición a la atención de VIH orientada a adultos en Lima, Perú. Evaluamos la viabilidad y la eficacia potencial,
incluidos los cambios personales en la adherencia auto-reportada, criterios psicosociales (NIH Toolbox), y preparación
para la transición (cuestionario “Estoy en el TRAC”, lista de verificación “Got Transition”). Desde octubre de 2019 hasta
enero de 2020, enrolamos a 30 adolescentes (15 a 21 años). La intervención de nueve meses consistió en apoyo logístico,
de adherencia y social brindado por técnicos de enfermería y sesiones grupales para mejorar tanto el conocimiento y las
habilidades relacionados con la salud, como el apoyo social. En cuanto a la preparación para la transición, observamos
mejoras comparada con el basal. También observamos una fuerte evidencia de mejoras en la adherencia, apoyo social,
autoeficacia y estrés, que se mantuvieron, generalmente, tres meses después del fin de la intervención. Todos los participantes seguían en tratamiento después de 12 meses. La intervención fue factible y potencialmente efectiva para tender
un puente en la transición a la atención del VIH para adultos. Esto amerita una evaluación a mayor escala y que incluya
criterios clínicos.

Valentina Vargas and Milagros Wong these authors have contributed
equally to the work.
Extended author information available on the last page of the article

List of abbreviations
ALWH	adolescents living with HIV.
ART	antiretroviral therapy.
DOT	directly observed treatment.
HIV
human immunodeficiency virus.
MSM	men who have sex with men.
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Introduction
Expanded access to antiretroviral therapy (ART) has led to
major improvements in the survival of children who acquire
HIV early in life. This means that providers and programs
are faced with the challenge of caring for a group of patients
living with HIV that is also dealing with the many developmental, emotional and behavioral issues of adolescence.
These include the desire for peer acceptance, vulnerability
to mental health and substance use disorders, and the potential consequences of early sexual debut (e.g., pregnancy,
HIV transmission, other sexually-transmitted infections)
[1–6]. And, adolescents living with HIV (ALWH) may
lack the coping strategies and support needed to effectively
manage common HIV-related challenges, such as diagnosis
disclosure, HIV-related stigma and social isolation, neurocognitive delays, and navigating romantic relationships [1–
3, 7–10]. In spite of their unique needs, ALWH have rarely
been targeted for intervention studies to improve health
outcomes [11–13]. The absence of tailored interventions
for adolescents may in part explain their disproportionately
high rates of attrition to care relative to other age groups
[14, 15] and suboptimal rates of viral suppression and medication adherence during adolescence [16–18].
For many ALWH, the transition to adult HIV care is a
tumultuous time, marked by episodic care and declines in
HIV viral load suppression and CD4 cell counts [19, 20].
This transition, which often occurs in late adolescence, can
be accompanied by logistical and emotional challenges, as
adolescents find themselves newly independent with different medical providers in an unfamiliar and often less
supportive environment [21, 22]. The transition may be
particularly challenging for ALWH who are not adequately
prepared, with important gaps in life skills and HIV-related
knowledge.[23, 24] These deficits, along with a low level
of caregiver or health provider support, differences in care
cultures between pediatric and adult clinics, out-of-pocket
expenses, and challenges related to transportation and health
insurance, contribute to unsuccessful transitions to adult
care.[10, 25–29] Although retention rates post-transition are
heterogenous across settings, they tend to fall well below
95-95-95 targets, and adolescents with evidence of disease
progression, unsuppressed viral load, or unstable adherence prior to transition are at particularly high risk of poor
outcomes in the post-transition period.[30, 31] Although
several reviews suggest good transition outcomes may be
achieved with individualized transition plans that address
the multifaceted needs of adolescence [10, 22, 32–34], there
are few rigorous studies testing promising interventions [35,
36] and a notable lack of evidence on which interventions
might be most effective in supporting ALWH through this
period.
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Alongside an urgent need to identify effective transition
interventions is a growing recognition of the need for interventions that are tailored to local context and to specific
subgroups. A recent review on care transition studies for
ALWH identified an absence of studies from Latin America
and the Caribbean, where the experiences of ALWH likely
differ from those in high-income or high prevalence settings
[36]. There is also a stark need for transition studies among
adolescents with behaviorally-acquired HIV[10], including
young men who have sex with men (MSM) and transgender women, as their transition experiences may differ from
those of adolescents living with perinatal HIV infection
[37]. As a first step toward addressing these research gaps,
we conducted a pilot study to examine whether an intervention for ALWH, rooted in community-based support by an
entry-level health worker, could be a feasible approach for
bridging the transition to adult HIV care among a diverse
group of adolescents in the urban Latin American setting of
Lima, Peru.

Methods
Study setting
In Peru, there are an estimated 91,000 people living with
HIV, with the highest concentration in the capital, Lima
[38]. While perinatal infection constitutes the majority of
HIV infections in younger adolescents, Peru’s HIV epidemic has remained concentrated [39] among MSM and
transgender women, with one in ten and one in three thought
to be living with HIV. Between 2017 and September 2021,
there were 8951 new cases of HIV diagnosed among youth
between the ages of 15 and 24 years in Peru, and 79% of
these (n = 7041) occurred in men [40].
ART was made available free-of-charge through the public sector in 2004 and remains largely centralized with most
patients receiving treatment through public sector hospitals.
Care under Peru’s National HIV Program is provided by a
multidisciplinary team of providers including physicians,
nurses, psychologists, and peer-supporters. ART is typically
dispensed monthly, but may be dispensed at longer intervals
for patients who have established consistent adherence.
For adolescents that acquired HIV in early childhood,
the transition from a pediatric to an adult HIV clinic often
occurs at age 18, though it may occur as young as 15 for adolescents transitioning within the same health facility. Older,
newly-diagnosed adolescents may transition directly into
adult HIV care, bypassing the pediatric clinic. Pregnancy
during adolescence is common with 17% of 20- to 24-yearold women giving birth before age 18 [41]. If an adolescent in pediatric care becomes pregnant, she immediately
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transitions to an adult HIV clinic, regardless of age. The
existing standard of care for adolescents transitioning to
adult care includes a public health insurance referral and a
series of consults with a nurse, infectious disease specialist, psychologist, and social worker prior to transition. The
patient is given a report from each provider team, which the
ALWH is responsible for bringing to their first adult clinic
visit. Administrative requisites for transition often vary by
individual but may include registration for public health
insurance, procurement of a national ID card (e.g., for foreign migrants), or securing a health center transfer (i.e., due
to housing relocation).
While, we know of no published studies examining
health outcomes among ALWH following transition to adult
care in Peru, studies suggest that adherence, CD4 cell count,
and viral suppression decrease throughout adolescence [17],
with lack of positive caregiver support a major barrier to
treatment adherence [42].

Participants
We included ALWH aged 15 to 21 years who were on or
newly initiating ART, enrolled in HIV care at a participating public sector clinic, and scheduled to transition to adult
HIV care, either due to a recent HIV diagnosis or because
they had aged out of their pediatric clinic. We consecutively
enrolled patients representing the three common transition experiences in this setting, aiming for approximately
ten participants per group: adolescents transitioning from
a pediatric clinic to an adult clinic at a new facility; adolescents transitioning from a pediatric to an adult clinic
within the same facility; and adolescents newly initiating
treatment in an adult facility. ALWH who were previously
lost from care during transition but interested in re-engaging
in treatment were also eligible to participate. Adolescents
were excluded if they lived outside of metropolitan Lima.
Enrollment took place from October 2019 to January 2020
at three public sector hospitals (one pediatric facility and
two facilities with distinct on-site pediatric and adult clinics). Ministry of Health clinical collaborators consecutively
referred eligible participants to study staff. A Youth Advisory Board comprising a diverse group of young people living with HIV provided feedback on all aspects of the study.
Adolescents who had previously withdrawn from care were
referred by their clinicians or Youth Advisory Board members and contacted by study staff.

Study intervention
The intervention was nicknamed “PASEO” (meaning
‘crossing’ or ‘passage’ in Spanish) after its core elements:
peer engagement, accompaniment, support and education.

In short, PASEO aimed to provide in-person accompaniment to ALWH throughout the transition process through
the provision of individualized support, including adherence support, to address barriers to care and treatment (e.g.,
transport costs, inaccessibility of services, lack of caregiver
support) by providing medical, material, and social support
delivered by compensated entry-level or lay health workers
who liaise with formal health services [43].
PASEO also aimed to foster health-related skills, knowledge, and psychosocial well-being needed to thrive in the
adult clinic and more broadly. Intervention activities were
delivered in two phases, an intensive phase and a taper phase
(see Table, Electronic Supplementary Materials 1, which
describes the components of the intervention). The intensive
phase began just prior to transition (defined as the last date
of care at the pediatric clinic or, for adolescents initiating
treatment directly in an adult clinic, the ART initiation date)
and ended after six months. A three-month taper phase,
during which the intensity of study activities was reduced,
followed the intensive phase. Below, we describe each intervention component in detail as well as adaptations made to
accommodate stay-at-home orders invoked on March 15,
2020, due to the SARS-CoV-2 pandemic. Participants had
received between 1.4 and 5.3 months of in-person intervention (median: 3.1 [interquartile range (IQR): 2.2, 4.2]) when
in-person activities were suspended and programming was
implemented virtually. Adolescents were provided phone
credit to enable participation in virtual programming.
Health system navigation and clinic accompaniment. To
facilitate the transition to care in the adult clinic, trained
health promoters (entry-level health workers with a technical degree) employed by the nongovernmental organization Socios En Salud accompanied adolescents to their
first appointments; facilitated enrollment in public health
insurance and completion of other administrative requisites; helped troubleshoot logistical and/or social challenges
(e.g., housing instability); and served as a liaison between
the patient and pediatric and adult clinical providers. Clinic
visit transportation was provided based on economic need,
as determined by the study social worker. All but one participant had attended at least one accompanied in-person clinic
visit prior to SARS-CoV-2 stay-at-home orders. The exception was an individual who was scheduled to re-initiate care
in mid-March 2020. While hospital guidelines precluded
in-person accompaniment for this participant, intervention
staff coordinated with HIV program staff to ensure that adolescent would be seen in the clinic. Study staff coordinated
private telehealth appointments for adolescents requiring
clinical consultation during stay-at-home orders.
Routine check-in visits. Health promoters visited the participant’s home or another mutually-agreed upon location at
least monthly to review ART adherence, identify barriers to
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care and adherence, remind patients of upcoming medical
encounters, screen for and follow-up on clinical and social
problems and offer social support. The frequency of checkins was individualized and commensurate with the level of
support needed. Visits tended to occur more frequently for
participants lacking family support, re-initiating ART or
with a history of unstable adherence.
Directly Observed Treatment (DOT). Home-based DOT
was offered to adolescents identified as at risk of non-adherence (based on pediatric health provider assessment or a
detectable viral load at one of two previous measurements).
ALWH newly initiating ART chose whether they wished to
receive DOT. Eligible ALWH who opted into DOT were
assigned to a Ministry of Health community health worker
from the same neighborhood to observe ART ingestion daily,
ensure treatment was taken as prescribed and offer social
support. Following invocation of stay-at-home orders, DOT
was conducted virtually by Socios En Salud health promotors via telephone, video or short message service, depending on participant preference. Some participants elected
to participate in group video DOT, creating an additional
opportunity to build social support.
Social support groups, health education sessions and
skill-building workshops. Social support groups took place
at least once monthly (10 adolescents per group). The twohour sessions were facilitated by a Peruvian study psychologist and one peer youth living with HIV. Based on timing
of enrollment, adolescents were eligible to have attended
between two and five in-person sessions prior to stay-athome orders. Conducting these sessions online was largely
unsuccessful: many adolescents felt they lacked privacy
at home to discuss personal topics [44], and others could
not use video due to unstable internet. To build and sustain
social connectedness, staff implemented online social activities including an HIV-related meme competition, a TikTok
video competition, and a virtual talent show.
Health education sessions and skill-building workshops
were conducted on topics such as HIV, substance use, sexual health, self-esteem, nutrition, and gender and sexual
identity. In-person sessions took place at least once monthly
(coinciding with social support group sessions), while virtual sessions took place one to three times weekly (total of
41). For virtual sessions, participants could join live, allowing interaction with the speaker and other participants via
chat, or view a recording.
Mental health screening, referral and support. Participants were evaluated for depressive symptoms using the
Patient Health Questionnaire-9 (PHQ-9), a tool previously
validated in Spanish [45], and widely used in Peru [46].
Adolescents screening positive for mild or greater depressive symptoms (PHQ-9 ≥ 10) or with suicidal ideation were
evaluated by Socios En Salud’s mental health program and
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offered Psychological First Aid [47] and referrals as needed.
Participants with severe depressive symptoms (PHQ-9 ≥ 20)
or suicidal ideation were offered linkage to free, specialized mental health services provided by the Peru Ministry
of Health and delivered at nearby community mental health
centers [48].

Data collection
Data collection took place from October 2019 to January
2021 and included indicators of intervention feasibility
and potential effectiveness, and social, clinical, and demographic factors that could challenge transition.
Feasibility indicators aligned with selected dimensions
of acceptability and demand [49]. Acceptability focuses
on the extent to which a program is judged as suitable or
attractive. We assessed acceptability through study refusal
rates (i.e., the proportion of potentially eligible individuals
for the study who chose not to participate) and intervention
retention rates (i.e., the proportion of individuals who were
retained in the intervention). The demand domain describes
the extent to which a new intervention is likely to be used.
We assessed demand through intervention retention rates
and group attendance for study activities. Group attendance
was assessed by the proportion of individuals who attended
at least one session, and the median number of groups
attended by participants who attended at least one session.
Preliminary evidence of effectiveness is an impact indicator examining whether a new intervention shows promise
of success with the intended population. We generated preliminary evidence of effectiveness by calculating changes
in transition readiness at 9-months, relative to baseline, and
in self-reported adherence, perceived instrumental and emotional support, self-efficacy and stress at 6, 9, and 12-months,
relative to baseline. Follow-up measurements corresponded
to the end of the intensive phase, the end of the taper phase,
and three months after intervention, respectively.
Baseline clinical data, including CD4 cell count and
viral load, were recorded from clinical charts. Follow-up
measurements were rarely available due to testing disruptions resulting from the SARS-CoV-2 pandemic.
Instruments. Participants self-administered surveys in
Spanish on a tablet device. We assessed self-reported adherence during the prior 30-day period with three questions:
“How many days did you miss at least one dose of any of
your ART medications?”; “How often did you take your
ART medications correctly?” (5-point scale: always [= 5],
almost always [= 4] sometimes [= 3], rarely [= 2], never
[= 1]); “How well would you say you took your HIV medications, as directed by your doctor?” (6-point scale: excellent [= 6], very good [= 5], good [= 4], okay [= 3], bad [= 2],
very bad [= 1]). We assessed perceived instrumental support,
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emotional support, perceived stress, and self-efficacy using
the Spanish fixed-form version of the NIH Toolbox Emotion Battery (version 2.0) for ages 18–85. All have a 5-point
ordinal scale ranging from “never” to “always”, with higher
scores indicating higher levels [50, 51]. We evaluated transition readiness with two scales. “Am I On TRAC?” [52]
consists of knowledge and behavior indices, which we
adapted to the local context (see Text, Electronic Supplementary Materials 2, which describes the adaptations to the
questionnaire). The knowledge scale assesses the respondent’s health condition and general medical self-care. The
behavior scale measures the frequency with which respondents engage in individual health-related behaviors related
to the developmental model of transition. We also used the
Got Transition? checklist (version 2.0), which assesses personal health knowledge and use of medical services [53].
The questionnaire has a 3-point scale ranging from “not my
responsibility” to “yes, I know this.” For both measures, we
report the summed score of responses for each subscale;
higher scores indicate greater knowledge, engagement or
use.

Statistical analysis
Feasibility indicators were reported as descriptive statistics.
To examine changes in outcomes during the different phases
of intervention implementation, we calculated frequencies,
medians, and interquartiles ranges across time-points and

calculated within-person change from baseline to each of
the three follow-up points and tested whether this quantity
differed from zero, using paired t-tests or Wilcoxon signed
rank tests, as appropriate. For the NIH toolbox measurements, we report raw scores instead of the t-values validated
in a U.S. population. To understand whether potential effectiveness differed among subgroups, we stratified analyses
by early childhood versus recent diagnosis and whether
the adolescent had been lost from care or had a history of
chronic non-adherence. Data were analyzed using SAS version 9.4 (Cary, NC).

Compliance with ethical standards
The authors declare no conflicts of interest. Ethical approval
was granted in Peru by the Institutional Research Ethics
Committees of the Instituto Nacional de Salud del Niño,
Hospital Nacional Arzobispo Loayza, and Hospital Nacional Hipólito Unanue. In addition, ethical approval was
granted by the Institutional Review Board (IRB) of Harvard Medical School in the USA. Written informed consent
was obtained from adolescents 18 years of age and over or
from guardian(s) of adolescents < 18 years. Participants < 18
years provided informed assent. Three adolescents < 18
years without a guardian provided assent and were granted
a waiver of consent.

Table I Baseline characteristics of adolescent participants transitioning to adult HIV care, Lima, Peru
Characteristics
All
Early childRecent
participants hood infection infection
N = 30 n(%)a N = 19 n(%)a N = 11
n(%)a
Age, in years, median [IQR]
19 [18–20] 19 [18–20]
19 [18–20]
Female assigned at birth
12 (40)
11 (58)
1 (9)
Female gender identity
13 (43)
11 (58)
2 (18)
Identifies as MSM
10 (33)
1 (5)
9 (82)
Pregnant
4 (13)
3 (16)
1 (9)
CD4 count cells/mm3 median [IQR]
544
553
535
[349–615]
[381–608]
[331–608]
Days from CD4 test to enrollment median [IQR]
130
235
55 [36–63]
[51–272]
[127–322]
Lost from care at the time of enrollment
6 (20)
6 (20)
0 (0)
Venezuelan nationality
5 (17)
1 (5)
4 (36)
At least one living parent
19 (63)
8 (42)
11 (100)
At least one traumatic life eventb
21 (70)
11 (58)
10 (91)
Experienced sexual abuse (rape, attempted rape, or any type of forced or threatened sexual act)b
12 (40)
5 (26)
7 (64)
Urban hassles index median [IQR] (range 0–96)c
20 [13–27] 19 [11–27]
21 [17–27]
Unstable housing
4 (13)
4 (21)
0 (0)
16 (57)
10 (56)
6 (60)
Depression (mild to severe, N = 28)
a
Unless otherwise noted
b

Lifetime traumatic events were measured with the Life Events Checklist for DSM-5 (LEC-5) [54, 55]

c

We assessed exposure to daily stressors using an adapted version of the 17-item Urban Hassles Index [55, 56], a tool designed to measure
stressors affecting adolescents living in urban environments
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Results
We enrolled 30 ALWH, with a median age of 19 years [IQR:
18–20] (Table I). The cohort included 19 (63%) ALWH who
acquired HIV in early childhood, 13 (43%) ALWH who
identified as female (including one transgender woman),
10 (33%) MSM, five (17%) Venezuelan nationals, and four
young pregnant women (13%). Six (20%) had been lost
from care at the time of enrollment. Of the 14 ALWH who
transitioned from a pediatric clinic and were retained in
treatment at enrollment, 10 (71%) had a suppressed viral
load. The median number of self-reported days with at least
one missed dose in the last 30 days was 2 [IQR: 0–13],
and over half of participants reported taking their medications correctly “always” or “almost always” (score ≥ 4).
Median emotional and instrumental support scores fell at

the midpoint of the range of possible values while median
self-efficacy and perceived stress fell below the midpoint of
the range of possible values and median transition readiness
fell at or above the midpoint of possible values (Table II).

Feasibility indicators
Of 36 adolescents referred for participation, six refused to
participate (16.7%). Four were adolescents who had previously withdrawn from HIV care and did not wish to reengage. Two opted out because of scheduling conflicts with
study activities. Once enrolled, no participant withdrew
from the nine-month intervention, 12-month research study,
or ART (12 months of follow-up). Of the 30 adolescents, all
but three (90%) attended at least one in-person social support session. Based on timing of enrollment, 10 participants

Table II Within-person changes in key outcomes among PASEO intervention participants (N = 30)
Outcome (range of possible
Score
Within- person change from
P-value,
values)
median [IQR]a
baseline
within- person change
median [IQR]a
from baselinea
Baseline 6 mos.
9 mos.
12 mos.
6 mos.
9 mos. 12
6 mos. 9 mos. 12
mos.
mos.
Self-reported adherence to ART
Doses missed last 30 days,
2
0.5
1
0.5
0
-1
-1
0.03d 0.03d
0.01d
b,c
(0–30)
[0, 13]
[0, 2]
[0, 3]
[0, 2]
[-11, 0]
[-11, 0] [-12, 0]
How often did you take your ART 4
5
4
5
1
0
1
0.01d 0.01d
0.02f
medications correctly,
[2, 5]
[4, 5]
[4, 5]
[4, 5]
[0, 2]
[0, 2]
[0, 2]
last 30 days? (1–5)c,e
How do you consider that you
4
5
4
5
1
0
1
0.001d 0.09f
0.02f
took your ART medications,
[3, 4]
[4, 6]
[3, 5]
[4, 5]
[0, 2]c
[-1, 2.] [0, 2]
as directed by your doctor, last 30
days? (1–6)c,e
Psychosocial outcomes
Emotional support (7–33)e
20
22
24.8
25.8
1
1
2
0.21f 0.10d
0.03f
[13, 29] [17, 31] [16, 31]
[18.7, 32.7] [-2, 5]
[-2, 5]
[-1, 10]
Instrumental support (8–40)e
24
26
30
27.5
0
2.6
2
0.67d 0.07d,g 0.004d
g
g
[16, 31] [19, 31] [21, 36]
[24, 34]
[-3, 4.3]
[-1, 6]
[0, 8]
Self-efficacy (10–40)e
23
25.5
27
24.7
1
3
1.5
0.57d 0.03f,g 0.06f
[19, 28] [20, 30] [21, 33]g [21, 33]
[-4, 5]
[-2, 6]g [-2, 8]
Perceived stress (10–40)b
19
19.2
18
18
-0.5
-1.5
-1
0.59f 0.09d
0.04f
[17, 23] [18, 22] [15, 20]
[17, 20]
[-3, 3]
[-4, 2]
[-5, 2]
Transition readinessh
Got transition, my health (0–18)e 13.8
-16
--1.9
--< 0.001f -[12, 16]
[15, 18]
[0, 4]
Got transition, health care usage
21
-24.1
--2.4
--< 0.001f -(0–28)e
[18,
[22, 27]
[1, 6]
23.7]
Am I ON TRAC, knowledge
48
-50.5
--3.3
--0.001d -(12–60)e
[38.7,
[47, 55]
[1, 8]
52]
Am I ON TRAC, behavior (9–45)e 28
-32
--3
--0.003f -[24, 31]
[27, 35]
[0, 6]
a
6, 9, and 12 months after enrollment correspond to the end of the intensive phase, the end of the taper phase, and three months after the intervention, respectively. bLower=favorable. c N=27 for baseline measurement and all within-person change comparisons. Three participants on
ART for less than 7 days at the time of baseline data collection were excluded. d Wilcoxon signed rank. e Higher=favorable. f Paired T-test. g
N=29. h Transition readiness was assessed at baseline and 9 months.
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were eligible to have participated in five in-person social
support sessions and 20 participants were eligible to have
participated in three sessions. The median number of sessions attended by those participating in ≥ 1 session was two
[IQR: 2, 3]). There were 41 virtual sessions offered, and 28

adolescents (93%) participated in at least one of these sessions (median number of sessions attended by those who
participated = 34.5, [IQR:16.5–39.8]).

Fig. 1 Treatment adherence in
the last 30 days among adolescents living with HIV in Lima,
Peru. In the graph of the number of days in the last 30 that
at least one dose was missed,
the bottom and top of the gray
box represent the 25th and 75th
percentiles, respectively. The
dark horizontal like represents
the median. The vertical error
bars encompass the full range
of values.
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Preliminary evidence of effectiveness
Changes in adherence, psychosocial scale scores, and transition readiness scores are shown in Table II, Figs. 1, 2 and 3.

In transition readiness, we observed within-person improvements related to personal health (+ 1.9 points, p < 0.001),
healthcare usage (+ 2.4 points, p < 0.001), knowledge (+ 3.3
points, p = 0.001), and behavior (+ 3 points, p = 0.003) at

Fig. 2 Within-person changes in psychosocial outcome scores among adolescents living with HIV in Lima, Peru. The bottom and top of the
gray box represent the 25th and 75th percentiles, respectively. The dark horizontal line represents the median. The vertical error bars encompass
the full range of values.

Fig. 3 Within-person changes in transition readiness among adolescents living with HIV in Lima, Peru. The bottom and top of the gray box
represent the 25th and 75th percentiles, respectively. The dark horizontal like represents the median. The vertical error bars encompass the full
range of values.
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the end of the intervention, relative to baseline (Table II).
Results for adherence and psychosocial constructs followed
a pattern of modest improvements in each scale between
baseline and six-months, which increased further by ninemonths and were generally sustained at twelve months
(Table II). Although sample sizes were small for subgroup
analyses, we observed evidence of improvements in transition readiness across all subgroups as well as improvements
in adherence among adolescents living with HIV since early
childhood, improvements in psychosocial indicators among
adolescents with newly acquired HIV, and improvements
in both metrics among adolescents with a history of nonadherence (Electronic Supplementary Materials 3-5).

Discussion
We provide quantitative evidence supporting the feasibility and potential effectiveness of a community-based intervention designed to improve health outcomes for ALWH
in Lima, Peru. The adolescents in this cohort were diverse
in terms of their medical needs and social circumstances,
which included depression, housing instability, poverty,
lack of parental support, pregnancy and living in a foreign
country. A key strength of the intervention was its comprehensive nature (i.e., it was designed to address a broad spectrum of unmet social and health needs) and individualized
design (i.e., it sought to respond to each adolescent’s needs,
tailoring the intensity of support offered to each participant).
Research has highlighted the limited efficacy of a “one
size fits all” approach for community-based interventions
[10, 57, 58], in part because subgroups at highest risk may
need extra support [30, 59]. In this intervention, entry-level
health workers filled gaps in care, provided linkages, liaised
with providers, and literally accompanied adolescents as
they transitioned to adult care.
We found the PASEO intervention to be highly feasible
based on metrics of acceptability and demand. There was
a low refusal rate for enrollment, no participants were lost
to follow up, and adolescents demonstrated high-attendance
in group sessions. The potential effectiveness of PASEO
is supported by within-person improvements in adherence, psychosocial indicators, and transition readiness; this
improvement was often sustained three months after the
intervention’s intensive phase. Importantly, these improvements appear to hold up across subgroups of adolescents
characterized by timing of diagnosis (early childhood infection versus recent diagnosis) and among those with a history
of non-adherence. This suggests that the lay health workers were effective at individualizing support to adequately
meet the needs of each adolescent. Importantly, these data
also corroborate that PASEO aligns with World Health

Organization criteria for adolescent-friendly care in that it
was acceptable (adolescents were willing to engage), equitable (all adolescents could access it), appropriate (offering
the right menu of services) and effective (resulting in a positive contribution to health) [60]. To further increase equity,
adaptations may be needed to ensure it is acceptable and
effective for transgender women, as we only enrolled one
in this study.
A number of intervention studies addressing the transition
period are underway in low-or-middle-income and highburden settings [61, 62]. While these studies will contribute importantly to knowledge on evidence-based practices,
there is a notable lack of intervention studies addressing
the transition to adult care in South America. This disparity
reflects a broader knowledge gap related to effective interventions for ALWH in the Latin American and Caribbean.
One recent systematic review of interventions for ALWH
found only six studies that discussed linkage to care, none
of which were from Latin America [63]; another, focused on
psycho-social support interventions, identified six studies,
but found none outside the U.S. or Africa. An intervention
that was effective in improving continuity of care and psychosocial health outcomes among ALWH in South America
would therefore contribute to filling an important research
and implementation gap. And, the fact that the six adolescents who had been lost from care at enrollment remained
engaged in ART at the end of the study, suggests that the
PASEO intervention also may be an effective strategy for
re-engaging ALWH who are lost from care.
This pilot study was underway when the SARS-CoV-2
pandemic emerged, during which stay-at-home orders were
intermittently instated. These circumstances required us to
adapt the intervention to a virtual format; however, improvements in key metrics suggest that the pillars of the intervention (accompaniment, social support, skills-building) were
preserved under this hybrid model. The lack of a control
group precludes definitively concluding that the intervention
caused these improvements; however, baseline measurements preceded SARS-CoV-2, while follow-up measurements occurred in the first six months of the pandemic;
therefore, the expected time trend in these outcomes would
likely have attenuated any PASEO-related improvements
[44]. While unplanned, the intervention adaptations could
be considered a strength: the flexibility and high participation rates despite the pandemic suggest that the feasibility
metrics are even more notable. And, successful adaptations
open the possibility for flexible delivery across a variety of
in-person parameters. The pandemic also resulted in temporary suspension of CD4 cell count and viral load testing,
which prevented us assessing biologic endpoints. Finally,
this analysis reports quantitative metrics of transition and
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well-being, and inferring clinical meaningfulness from
the observed improvements is not straightforward. While
within-person changes in scale scores for key constructs targeted by the intervention support its potential effectiveness,
understanding participant and provider perspectives will be
critical to its overall evaluation, as will identification of any
differential effects across subgroups. Results from qualitative work with these groups will be reported.

Conclusions
In conclusion, the PASEO intervention was feasible and
demonstrated promise for improving myriad self-reported
health outcomes in a diverse cohort of ALWH. Future studies should include a large-scale impact evaluation including
biological outcomes and assessment of long-term effectiveness beyond the life of the intervention.

Additional files
Additional file 1: Electronic Supplementary Materials.
Information on file format. Key components of intervention, overview of intervention implementation, adaptation
of the “Am I on TRAC” transition readiness questionnaire,
analyses of effectiveness outcomes, stratified by early
childhood versus recent diagnosis and whether the adolescent had been lost from care or had a history of chronic
non-adherence.
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